Compare the prognosis of pancreatic cancer patients with different treatment modalities and use machine learning methods to build predictive models
PC patients may benefit from more intensive multimodal therapies, which provides novel insights into predicting PC survival prognosis and highlights the potential of machine learning in biomarker identification and disease prognosis.
Authors
- Weimin Wang (ORCID: https://orcid.org/0000-0002-1085-3766)
- Yunfan Wang
- Xu Guang Yan
- Tao Li (ORCID: https://orcid.org/0000-0003-3831-901X)
- Lingling Fan (ORCID: https://orcid.org/0000-0002-2428-9297)
- Yizhou Deng (ORCID: https://orcid.org/0000-0002-7170-5468)
- Chao Jiang (ORCID: https://orcid.org/0009-0000-7829-8239)
- Shujing Kong
Institutions
- Jiangsu University (CN)
- State Administration of Traditional Chinese Medicine of the People's Republic of China (CN)
- Yixing People's Hospital (CN)
- Yangzhou University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-11-26
- DOI
- https://doi.org/10.3389/fmed.2025.1629324
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Yangzhou University